FDA Rejects Pfizer's Application for Injectable Cox-2

Drug Industry Daily
KEYWORDS FDA / NDA
A A

The FDA has issued Pfizer a “non-approvable” letter for parecoxib, a non-narcotic injectable Cox-2 inhibitor already approved and marketed in the European Union (EU).

To View This Article:

Login

Subscribe To Drug Industry Daily